Recent Updates
Recently added Catalysts
HYPR Positive Sentiment

Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Hyperfine, Inc. announced its participation in the Jefferies Global Healthcare Conference and BTIG Tech-Enabled Healthcare Conferences in November 2026. The company, known for its FDA-cleared AI-powered portable MRI system, will host investor meetings during these events. This engagement highlights Hyperfine's commitment to connecting with investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Hyperfine will participate in notable healthcare conferences.
  • The company is recognized for its innovative AI-powered MRI system.
  • Management will engage directly with investors.

Full Press Release Details

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will host investor meetings at two healthcare conferences in November. UPCOMING CONFERENCES 2026 Jefferies Global Healthcare Conference in London - Wednesday, November 18 and Thursday, November 19, 2026. Management will be hosting in

Frequently Asked Questions

What conferences will Hyperfine attend?

Hyperfine will participate in the Jefferies and BTIG healthcare conferences.

When are the conferences scheduled?

The conferences are scheduled for November 18 and 19, 2026.

What is Hyperfine known for?

Hyperfine is known for its FDA-cleared AI-powered portable MRI system.

Will Hyperfine host any meetings?

Yes, management will host investor meetings at the conferences.

ShareAdd on Google
Tags: HYPR Hyperfine AI-powered MRI healthcare conferences investor meetings
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$43M liquidity · $2M/mo burn
~15 mo
Low dilution risk